A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Endothelial Microparticles During Exercise In COPD Patients: Influence Of Inhaled Iloprost

A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Endothelial Microparticles During Exercise In COPD Patients: Influence Of Inhaled Iloprost

Methods: We performed an analysis of a subset of patients from an ongoing study in which patients with moderate-severe COPD were randomized in a blinded crossover design to received nebulized iloprost or placebo 30 minutes prior to a maximal cardiopulmonary exercise test. Supported, in part, by the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser: Okpechi, S C, Wyczechowska, D, DeBoisblanc, B P, Johnson, J, Ghonim, M A, Bauer, N, Boulares, A H, Lammi, M R
Format: Artikel
Sprache:eng
Schlagworte:
Chronic obstructive pulmonary disease
Exercise
Hypertension
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods: We performed an analysis of a subset of patients from an ongoing study in which patients with moderate-severe COPD were randomized in a blinded crossover design to received nebulized iloprost or placebo 30 minutes prior to a maximal cardiopulmonary exercise test. Supported, in part, by the National Institute of General Medical Sciences of the National Institutes of Health under award number U54 GM104940 (MRL); NIGMS Cardiovascular COBRE grant 1P306M206392-01A1 (MRL) Am J Respir Crit Care Med 2017;195:
ISSN:1073-449X
1535-4970